AI-generated from publicly available materials.Beckman Coulter Life Sciences has introduced the Vi-CELL BLU 2.0 Viability Analyzer Software, a significant upgrade designed to enhance cell viability workflows while ensuring compliance and data integrity.
This new software version aims to facilitate the transition from research to biomanufacturing by providing laboratories with advanced cell analysis tools. It builds upon the existing Vi-CELL BLU instrument, featuring improved algorithms for cell counting and customizable analysis settings that align with previous systems. This allows labs to modernize their processes without the disruption typically associated with new equipment transitions.
Key enhancements include role-based access controls, electronic signatures, and comprehensive audit trails, which are essential for maintaining compliance in regulated environments. These features not only streamline integration into Good Manufacturing Practices (GMP) but also ensure consistency across various projects and users.
This launch underscores Beckman Coulter's commitment to advancing scientific innovation in the biopharma sector. With the Vi-CELL BLU 2.0, laboratories can confidently accelerate their workflows, minimizing risks associated with adopting new technologies while ensuring reliable and scalable cell analysis.